Histogen Receives Decision To Grant European Patent Titled ‘CASPASE INHIBITORS AND METHODS OF USE THEREOF (FOR THE TREATMENT OF VARIOUS DISEASES)’ – Histogen (NASDAQ:HSTO) – Benzinga

21st October 2022